Maravai (MRVI) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $6.50 from $5.50 | Aug 7, 2026 |
| Wells Fargo | Maintained | Overweight | $5.50 from $4.50 | May 8, 2026 |
| Wells Fargo | Maintained | Overweight | $4.50 from $4.00 | Dec 15, 2025 |
| RBC Capital | Maintained | Outperform | $5.00 from $7.00 | Aug 12, 2025 |
| Craig-Hallum | Maintained | Buy | $10.00 from $12.00 | May 13, 2025 |
| Baird | Maintained | Neutral | $2.00 from $3.00 | May 13, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $5.00 from $7.00 | Mar 25, 2025 |
| UBS | Maintained | Neutral | $2.50 from $8.00 | Mar 21, 2025 |
| B of A Securities | Maintained | Buy | $8.00 from $9.00 | Mar 3, 2025 |
| Baird | Downgraded | Outperform → Neutral | $3.00 from $9.00 | Feb 26, 2025 |
| Goldman Sachs | Downgraded | Neutral → Sell | $4.25 from $7.00 | Dec 5, 2024 |
| Wolfe Research | Initiated Coverage | Peer Perform | — | Nov 14, 2024 |
| William Blair | Downgraded | Outperform → Market Perform | — | Nov 8, 2024 |
| Baird | Maintained | Outperform | $9.00 from $10.00 | Nov 8, 2024 |
| RBC Capital | Maintained | Outperform | $13.00 from $17.00 | Nov 8, 2024 |
| Goldman Sachs | Maintained | Neutral | $7.00 from $8.00 | Oct 8, 2024 |
| Wells Fargo | Initiated Coverage | Overweight | $10.00 | Aug 27, 2024 |
| RBC Capital | Maintained | Outperform | $15.00 | Aug 16, 2024 |
| Morgan Stanley | Downgraded | Overweight → Equal-Weight | $10.00 from $11.00 | Aug 13, 2024 |
| Goldman Sachs | Maintained | Neutral | $8.00 from $7.00 | Aug 8, 2024 |
Frequently asked questions
Is MRVI a buy, sell, or hold?
Analysts covering Maravai currently average a Buy rating: 5 buy, 3 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MRVI?
On Aug 7, 2026, Wells Fargo maintained Maravai at Overweight with a price target of $6.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.